# TP53 Mutation Types Reference
This page is the practical decoder for TP53 variant notation and mutation class.
The key idea is simple:
**A TP53 mutation is not one thing.**
The mutation type tells you whether:
* a harmful mutant protein is accumulating
* some p53 function remains
* p53 is absent altogether
* a mutation-specific strategy has any logical target
### Start with the notation
Most reports use one or both of these formats:
* **protein notation** such as `p.R175H`, `p.R248Q`, `p.P128fs`, or `p.R213*`
* **DNA notation** such as `c.524G>A` or splice-site notations like `c.375+1G>T`
The protein notation is usually the fastest practical clue.
### The main somatic mutation buckets
#### Hotspot missense gain-of-function mutations
Examples:
* `p.R175H`
* `p.R248Q`
* `p.R248W`
* `p.R273H`
* `p.G245S`
* `p.R249S`
* `p.R282W`
These usually produce a **stable full-length mutant protein**.
That matters because the problem is not just loss of tumour suppression. The mutant protein can actively promote tumour survival, invasion, metabolic rewiring, or treatment resistance.
This is the main setting where the logic of [Andrographis and Mutant p53](/myhealingcommunity-docs/testing-monitoring-and-biomarkers/tp53-in-cancer/andrographis-and-mutant-p53.md) becomes relevant.
#### Missense partial-loss mutations
These still produce a protein, but some residual p53 activity may remain.
They sit in an in-between zone:
* not clearly wild-type
* not clearly null
* sometimes still biologically salvageable in theory
This is where careful interpretation matters most.
#### Missense non-functional mutations
These still make protein, but the protein is essentially inactive.
There may be no meaningful gain-of-function effect, but there is also no reliable tumour-suppressor effect left.
#### Frameshift mutations
Examples look like:
* `p.P128fs`
* `p.R196fs*`
These usually create a garbled downstream sequence and then a truncated unstable protein.
In practice, this often behaves like a **null** state:
* little or no useful p53 protein
* no stable target to clear
* mutant-protein-degradation strategies become much less relevant
#### Nonsense or stop-codon mutations
Examples look like:
* `p.R213*`
* `p.Q167*`
These create a premature stop signal.
Again, this usually behaves like a **null** state rather than a stable mutant-protein state.
#### Splice-site mutations
Examples often look like:
* `c.[number]+1`
* `c.[number]+2`
* `c.[number]-1`
These disrupt RNA splicing and often result in truncated or absent protein.
Many behave functionally like null variants, but some need case-by-case interpretation.
#### Silent or synonymous changes
These do not change the amino acid directly.
Most are clinically unimportant, but some affect splicing or expression and should not be dismissed automatically without proper interpretation.
### The practical shortcut
If a report shows:
* `p.R175H`, `p.R248Q`, `p.R248W`, `p.R273H`, `p.G245S`, `p.R249S`, `p.R282W`\
think **stable hotspot mutant protein**
* `fs` or `fs*`\
think **frameshift / usually null**
* `*`\
think **nonsense / stop / usually null**
* `+1`, `+2`, `-1`, `-2` near a coding boundary\
think **splice-site disruption**
That shortcut is not a substitute for full interpretation, but it is often enough to sort the major bucket quickly.
### Why this page matters
This page exists because many downstream questions depend on the mutation class:
* Is [Fenbendazole and TP53](/myhealingcommunity-docs/testing-monitoring-and-biomarkers/tp53-in-cancer/fenbendazole-and-tp53.md) likely to retain its p53-dependent mechanism?
* Is [Andrographis and Mutant p53](/myhealingcommunity-docs/testing-monitoring-and-biomarkers/tp53-in-cancer/andrographis-and-mutant-p53.md) biologically relevant?
* Is [NAC in p53-Mutant Cancers](/myhealingcommunity-docs/testing-monitoring-and-biomarkers/tp53-in-cancer/questions-for-oncologists.md) more likely to be risky or potentially less problematic?
Those questions cannot be answered from the phrase **"TP53 mutation"** alone.
### Questions about your TP53 result?
If you want help interpreting a report, send a message here.
Name\
\
Email\
\
Message
\
Send message
{% hint style="info" %}
Include the exact TP53 variant if you have it.
{% endhint %}
### Key references
Targeting p53 pathways: mechanisms, structures and advances in therapy\
Natural products targeting the p53-MDM2 pathway and mutant p53\
{% hint style="warning" %}
This information is for education only. It is not medical advice, diagnosis, or treatment. Please speak with a qualified clinician before making changes to care, medication, or supplement use.
{% endhint %}
{% hint style="info" %}
© 2026 Abbey Mitchell. All rights reserved. Please share by URL rather than copying page text.
{% endhint %}
---
# Agent Instructions: Querying This Documentation
If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question.
Perform an HTTP GET request on the current page URL with the `ask` query parameter:
```
GET https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/tp53-in-cancer/somatic-tp53/tp53-mutation-types-reference.md?ask=
```
The question should be specific, self-contained, and written in natural language.
The response will contain a direct answer to the question and relevant excerpts and sources from the documentation.
Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.